PITTSBURGH--Victor Vogel, MD, MHS, will lead a newly established joint breast cancer program of the University of Pittsburgh Cancer Institute and Magee-Womens Hospital. He will also join the University of Pittsburgh as professor of medicine and epidemiology.
Dr. Vogel comes to Pittsburgh from the University of Texas M.D. Anderson Cancer Center, where he was responsible for recruiting the largest number of women onto the Breast Cancer Prevention Trial, the national study designed to determine the value of tamoxifen(Drug information on tamoxifen) (Nolva-dex) in preventing breast cancer in high-risk women.
"One of the program's most important missions," Dr. Vogel said, "will be to enhance delivery of care to women who face barriers, ie, older women or those who are poor or live in rural areas."